VALBIOTIS SA: Valbiotis presents the full results of the Phase II/III REVERSE-IT study: impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes

VALBIOTIS SA VALBIOTIS SA: Valbiotis presents the full results of the Phase II/III REVERSE-IT study: impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes 11-Sep-2023 / 17:40 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The i...

Related Keywords

United States ,France ,French ,American ,Agence Monet ,Carole Rocher ,Seitosei Actifin ,Marc Delaunay ,Rue Paul Vatine ,Health Science ,Public Affairs ,American Diabetes Association ,News Service ,International Diabetes Federation ,Valbiotis Executive Committee ,French Regulatory News ,Valbiotis Executive ,International Diabetes ,Valbiotis Universal Registration Document ,French Financial Markets Regulator ,True Paul ,Sa ,Valbiotis ,A ,Hase ,I Iii ,Reverse It ,Otum 63 ,Et Cest ,Dissemination ,Egulatory ,News , ,Qs ,Group ,